All Insights
Preliminary remarks on the Italian Government's urgent provisions for COVID-19
Osborne Clarke has prepared a report to help clients dealing with the various legal issues arising from the DPCM 8
Coronavirus | A guide for your business
The coronavirus represents a unique challenge for businesses playing their part in looking after staff and customers, while continuing to
Payback for medical devices: the uncertainty persists
Transparency obligations extended to medical device companies
Transparency obligations for medical device companies (members of Confindustria Dispositivi Medici): transfers of value made during 2020 must be published
The AP imposes its first GDPR fine on a Dutch hospital
Following a lengthy investigation, the Dutch Data Protection Authority (AP) concluded that a Dutch hospital did not take adequate technical
UK Supreme Court gives "skinny label" products (tentative) go ahead – good news for generic pharmaceutical companies and the NHS?
The decision in Warner Lambert v Actavis is good news for generic pharmaceutical companies who will feel emboldened to continue
What was driving the legal and business agenda in 2018, and what's coming up in 2019?
As we look forward to 2019, what has been driving the agenda over the past 12 months? Which issues will
What will Brexit mean for the Life Sciences sector – in a deal or a no deal scenario?
With less than four months until the UK officially leaves the EU, amid confidence votes and delayed votes in the
Next-generation connectivity: William Newton, Wiredscore
The internet “will become the fundamental lifeblood of a business… the average business loses about $300,000 for every hour that
Next-generation connectivity: Dr Flemming Moos, Osborne Clarke
"Well, the data deluge in my opinion is both an opportunity and a threat – at least if you don't